Hydralazine and Panobinostat Attenuate Malignant Properties of Prostate Cancer Cell Lines

• Main Authors: Mariana Brütt Pacheco (Author), Vânia Camilo (Author), Nair Lopes (Author), Filipa Moreira-Silva (Author), Margareta P. Correia (Author), Rui Henrique (Author), Carmen Jerónimo (Author)
• Format: Book
• Published: MDPI AG, 2021-07-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Among the well-established alterations contributing to prostate cancer (PCa) pathogenesis, epigenetics is an important player in its development and aggressive disease state. Moreover, since no curative therapies are available for advanced stage disease, there is an urgent need for novel therapeutic...